Milacron (MZIAQ) Form 3 Milacron / Ling An-Heid ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

An-Heid Ling

(Last) (First) (Middle)

C/O MILACRON HOLDINGS CORP.

10200 ALLIANCE ROAD, SUITE 200

(Street)

CINCINNATI OH 45242

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/11/2019

3. Issuer Name and Ticker or Trading Symbol
Milacron Holdings Corp. [ MCRN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
President, Mold-Masters

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.01 per share ("Common Stock")	148,906	D
Common Stock	4,750(1)	D
Common Stock	16,252(2)	D
Common Stock	11,989(3)	D
Common Stock	33,709(4)	D
Common Stock	40,153(5)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	07/09/2015	05/08/2023	Common Stock, par value $0.01 per share	316,242	6.64	D
Stock Option (right to buy)	(6)	06/24/2025	Common Stock, par value $0.01 per share	65,491	20	D
Stock Option (right to buy)	(7)	03/01/2027	Common Stock, par value $0.01 per share	16,935	18.42	D

Explanation of Responses:

1. Performance stock units - each performance stock unit represents a contingent right to receive one share of common stock. The performance stock units will vest and become exercisable at the end of the 3 calendar year period 2017-2019 based upon the satisfaction of certain performance criteria.

2. Performance stock units - each performance stock unit represents a contingent right to receive one share of common stock. The performance stock units will vest and become exercisable at the end of the 3 calendar year period 2018-2020 based upon the satisfaction of certain performance criteria.

3. Restricted stock units - each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units vest in equal annual installments of 33 1/3% on each of the first three anniversary dates of the grant date, March 1, 2017.

4. Restricted stock units - each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units vest in equal annual installments of 33 1/3% on each of the first three anniversary dates of the grant date, October 30, 2017.

5. Restricted stock units - each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units vest in equal annual installments of 33 1/3% on each of the first three anniversary dates of the grant date, March 1, 2018.

6. The options will vest and become exercisable in equal annual installments of 25% of the shares over a 4-year period on each anniversary date of the grant date, June 24, 2015, subject to the participant's continued service through each applicable vesting date.

7. The options will vest and become exercisable in equal annual installments of 25% of the shares over a 4-year period on each anniversary date of the grant date, March 1, 2017, subject to the participant's continued service through each applicable vesting date.

	/s/Hugh C. O'Donnell, as Attorney-in-Fact for Ling An-Heid	02/20/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.